← Eichor
Condition: Methamphetamine Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Methamphetamine Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
NA · 1 location(s) · University of Colorado, Denver · NCT06320366
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev
NA · 1 location(s) · Chestnut Health Systems · NCT06852170
PrEP Readiness Interventions for Sustained Motivation (PRISM)
NA · 1 location(s) · Florida International University · NCT06637436
LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis
Phase N/A · 1 location(s) · Elazığ Mental Health and Diseases Hospital · NCT07450027
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
NA · 1 location(s) · Gopalkumar Rakesh · NCT06830980
Psilocybin for Methamphetamine Addiction
EARLY_Phase 1 · 1 location(s) · Kevin Murnane · NCT06899594
A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06712446
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder
NA · 1 location(s) · Stanford University · NCT06578429
Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treat
Phase 2 · 1 location(s) · Washington State University · NCT06323837
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
Phase 2 · 1 location(s) · Carolyn Rodriguez · NCT05783817
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NA · 2 location(s) · Wake Forest University Health Sciences · NCT04927143
Ketamine for Methamphetamine Use Disorder
Phase 2 · 5 location(s) · University of Texas Southwestern Medical Center · NCT06496750
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamin
Phase 2 · 1 location(s) · Clear Scientific, Inc. · NCT06721494
Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder
Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06788587
Methamphetamine Cue-reactivity
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07086014
Testing Implementation Strategies to Scale-up a Multicomponent Continuum of Service Intervention for Families Involved i
NA · 1 location(s) · Chestnut Health Systems · NCT07365293
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
Phase 1 · 1 location(s) · BioCorRx Pharmaceuticals Inc · NCT07269873
Methamphetamine and Troriluzole
EARLY_Phase 1 · 1 location(s) · William Stoops · NCT06989853
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
NA · 1 location(s) · Oregon Health and Science University · NCT06461962
Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis
Phase N/A · 1 location(s) · Elazığ Mental Health and Diseases Hospital · NCT07459257
ECG Findings in Methamphetamine Use
Phase N/A · 1 location(s) · Elazığ Mental Health and Diseases Hospital · NCT07459244
Non-Abstinence Outcomes in Methamphetamine Use Disorder
NA · 1 location(s) · William Stoops · NCT07226596
Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users
Phase 2 · 4 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05854667
Smartphone Services for Stimulant Use Disorder
NA · 1 location(s) · DynamiCare Health · NCT07092059
Role of Pavlovian Mechanisms for Control Over Substance Use
Phase N/A · 1 location(s) · Technische Universität Dresden · NCT06701487
Friendship Bench for Women Who Use Methamphetamine in Vietnam
NA · 1 location(s) · Hanoi Medical University · NCT06789523
Creatine for Depressed Male and Female Methamphetamine Users
Phase 3 · 1 location(s) · Montana State University · NCT02568878
Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
NA · 1 location(s) · Queen's Medical Center · NCT06532370
Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder
NA · 1 location(s) · Shanghai Mental Health Center · NCT06457230
Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06444256
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.